Although angiotensin-converting enzyme inhibitors, angiotensin receptor blocker, sodium–glucose Cotransporter 2 inhibitors, and nonsteroidal mineral corticosteroid receptor antagonists have been used for the treatment of DN [3], the prevention and treatment of DN are still major clinical challenges. The gene discussed is ACE; the disease is liver dysplastic nodule.